Haptoglobin is an acute phase glycoprotein, secreted by hepatocytes and other types of cells including keratinocytes. Haptoglobin has been suggested to impair the immune response, inhibit gelatinases in the extracellular matrix and promote angiogenesis, but its role in psoriasis is obscure to date. Changes in haptoglobin glycan structure were observed in several diseases. The aim of our study was to investigate whether haptoglobin displays glycan variations in psoriasis. We found that the pattern of plasma haptoglobin glycoforms, following two-dimensional electrophoresis, exhibited significant quantitative differences in spot intensities between patients and controls. Quantitative and qualitative differences in glycan mass, between patients and controls, were found by mass spectrometry of glycopeptides from tryptic digests of protein isolated from both patients and controls. The number of distinct fucosylated glycoforms of peptides NLFLNHSENATAK and MVSHHNLTTGATLINEQWLLTTAK was higher in patients than in controls, but no fucosylated glycan was detected on peptide VVLHPNYSQVDIGLIK in either case. The number of peptides with distinct tri- and tetra-antennary glycans was higher in patients than in controls. Abundance or structure of specific glycans, which are present in haptoglobin from patients and different or missing in normal haptoglobin, might be associated to the disease activity.

Quantitative determination of haptoglobin glycoforms in Psoriasis

CIGLIANO, LUISA;CORSARO, MARIA MICHELA;BALATO, NICOLA;AYALA, FABIO;ABRESCIA, PAOLO
2010

Abstract

Haptoglobin is an acute phase glycoprotein, secreted by hepatocytes and other types of cells including keratinocytes. Haptoglobin has been suggested to impair the immune response, inhibit gelatinases in the extracellular matrix and promote angiogenesis, but its role in psoriasis is obscure to date. Changes in haptoglobin glycan structure were observed in several diseases. The aim of our study was to investigate whether haptoglobin displays glycan variations in psoriasis. We found that the pattern of plasma haptoglobin glycoforms, following two-dimensional electrophoresis, exhibited significant quantitative differences in spot intensities between patients and controls. Quantitative and qualitative differences in glycan mass, between patients and controls, were found by mass spectrometry of glycopeptides from tryptic digests of protein isolated from both patients and controls. The number of distinct fucosylated glycoforms of peptides NLFLNHSENATAK and MVSHHNLTTGATLINEQWLLTTAK was higher in patients than in controls, but no fucosylated glycan was detected on peptide VVLHPNYSQVDIGLIK in either case. The number of peptides with distinct tri- and tetra-antennary glycans was higher in patients than in controls. Abundance or structure of specific glycans, which are present in haptoglobin from patients and different or missing in normal haptoglobin, might be associated to the disease activity.
File in questo prodotto:
File Dimensione Formato  
Haptoglobin is an acute phase glycoprotein.pdf

accesso aperto

Tipologia: Abstract
Licenza: Accesso privato/ristretto
Dimensione 81.66 kB
Formato Adobe PDF
81.66 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11588/372516
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 9
social impact